SCHEMBL3172420

SCHEMBL3172420

CC(=O)NCCNc1cc(NC(=O)CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 4/20 0.46
▸ DRD3 P35462 4/20 0.46
▸ CACNA2D1 P54289 1/20 0.45
▸ CACNA1B Q00975 1/20 0.45
▸ CACNB1 Q02641 1/20 0.45
▸ CACNA1C Q13936 1/20 0.45
▸ SLC6A9 P48067 1/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ HTT P42858 2/20 0.42
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA7 P43166 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162235 0.95 SMN1; SMN2 (0.48) DRD2DRD3SMN1; SMN2KDM4EALDH1A1
SCHEMBL3169342 0.91 CA1 (0.45) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL3162253 0.88 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1MEN1KMT2ANPSR1
SCHEMBL3162806 0.87 JAK3 (0.51) DRD2SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL3163746 0.84 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1MEN1KMT2ANPSR1
SCHEMBL3171920 0.84 ADORA1 (0.47) KDM4EALDH1A1
SCHEMBL3163863 0.83 POLB (0.45) DRD2DRD3SMN1; SMN2KDM4EALDH1A1
SCHEMBL3163144 0.83 ADORA3 (0.46) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL3164831 0.83 MAPT (0.50) SMN1; SMN2KDM4EALDH1A1KMT2ANPSR1
SCHEMBL3164709 0.83 NPC1 (0.47) KDM4EALDH1A1MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback